WALTHAM, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming UBS Global Life Sciences Conference being held September 25 through 28, 2006 at the Grand Hyatt New York in New York City. Ron Zwanziger, Chief Executive Officer, and Chris Lindop, Chief Financial Officer, will attend. Their presentation is scheduled for Wednesday, September 27, 2006 at 12:30 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and through UBS' website at http://www.ibb.ubs.com/. A replay of the webcast will be available via the links above until October 27, 2006. During his presentation Mr. Zwanziger or Mr. Lindop may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
An investor presentation to be distributed at the conference will be made available to the public on the company's website via the link provided above.
Inverness Medical Innovations is a leading global developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno-diagnostics with a focus on women's health, cardiology and infectious disease. The Company's new product development efforts, as well as its position as a leading supplier of consumer pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics, are supported by the strength of its intellectual property portfolio. Inverness is headquartered in Waltham, Massachusetts.
